246 WhartonSCalannaSDaviesMDickerDGoldmanBLingvayIet al
In January of this year, the FDA noted that it had "received adverse event reports after patients used compounded semaglutide" and that "patients should not use a compounded drug if an approved drug is available to treat a patient." In July, the agency followed up with a notice that it had "received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products." And in August, Eli Lilly, the maker of Zepbound and Mounjaro, sent a series of cease-and-desist letters to providers urging them to stop prescribing compounded versions of those drugs
10.1128/mSphere.00585-19 55 LevineB.KroemerG
This degradation is often irreversible, meaning that returning the medication to proper storage conditions cannot restore its original potency
Current research investigating potential advantages beyond glycaemic regulation and weight reduction, including impacts on non-alcoholic fatty liver disease, cardiovascular outcomes, and renal protection, may broaden the therapeutic uses of these medicines
I still try to do this from time to time, but I get recognized a lot which makes it hard
